Frederik Peissert | Business Development
Philochem
Frederik Peissert graduated in Pharmaceutical Sciences at ETH Zürich and performed an industrial Ph.D. at Philochem AG in which he focused on the generation and characterization of novel fully-human monoclonal antibodies. Frederik is author of several peer-reviewed publications in international scientific journals and joined the Business Development team at Philochem in 2023.
Appearances:
Festival of Biologics Day 2 @ 15:30
Antibody-cytokine Fusions for Cancer Therapy: Late-Stage Clinical Results
last published: 22/Jul/26 17:05 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events